The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Neurological Biomarkers Revenue 1.5 Market Analysis by Type 1.5.1 Global Neurological Biomarkers Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Proteomics 1.5.3 Genomics 1.5.4 Imaging 1.5.5 Bioinformatics 1.5.6 Others 1.6 Market by Application 1.6.1 Global Neurological Biomarkers Market Share by Application: 2021-2026 1.6.2 Diagnostics 1.6.3 Drug Discovery 1.6.4 Personalized Medicine 1.6.5 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Neurological Biomarkers Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Neurological Biomarkers Market Players Profiles 3.1 Thermo Fisher Scientific 3.1.1 Thermo Fisher Scientific Company Profile 3.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Specification 3.1.3 Thermo Fisher Scientific Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 QIAGEN 3.2.1 QIAGEN Company Profile 3.2.2 QIAGEN Neurological Biomarkers Product Specification 3.2.3 QIAGEN Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Abbott 3.3.1 Abbott Company Profile 3.3.2 Abbott Neurological Biomarkers Product Specification 3.3.3 Abbott Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Merck 3.4.1 Merck Company Profile 3.4.2 Merck Neurological Biomarkers Product Specification 3.4.3 Merck Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Bio-Rad Laboratories 3.5.1 Bio-Rad Laboratories Company Profile 3.5.2 Bio-Rad Laboratories Neurological Biomarkers Product Specification 3.5.3 Bio-Rad Laboratories Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 Quest Diagnostics 3.6.1 Quest Diagnostics Company Profile 3.6.2 Quest Diagnostics Neurological Biomarkers Product Specification 3.6.3 Quest Diagnostics Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Cisbio Bioassays 3.7.1 Cisbio Bioassays Company Profile 3.7.2 Cisbio Bioassays Neurological Biomarkers Product Specification 3.7.3 Cisbio Bioassays Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Illumina 3.8.1 Illumina Company Profile 3.8.2 Illumina Neurological Biomarkers Product Specification 3.8.3 Illumina Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Roche 3.9.1 Roche Company Profile 3.9.2 Roche Neurological Biomarkers Product Specification 3.9.3 Roche Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Myriad RBM 3.10.1 Myriad RBM Company Profile 3.10.2 Myriad RBM Neurological Biomarkers Product Specification 3.10.3 Myriad RBM Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 Proteome Sciences 3.11.1 Proteome Sciences Company Profile 3.11.2 Proteome Sciences Neurological Biomarkers Product Specification 3.11.3 Proteome Sciences Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.12 Athena Diagnostics 3.12.1 Athena Diagnostics Company Profile 3.12.2 Athena Diagnostics Neurological Biomarkers Product Specification 3.12.3 Athena Diagnostics Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.13 Genewiz 3.13.1 Genewiz Company Profile 3.13.2 Genewiz Neurological Biomarkers Product Specification 3.13.3 Genewiz Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.14 Aepodia 3.14.1 Aepodia Company Profile 3.14.2 Aepodia Neurological Biomarkers Product Specification 3.14.3 Aepodia Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.15 BGI 3.15.1 BGI Company Profile 3.15.2 BGI Neurological Biomarkers Product Specification 3.15.3 BGI Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.16 Wuxi APP 3.16.1 Wuxi APP Company Profile 3.16.2 Wuxi APP Neurological Biomarkers Product Specification 3.16.3 Wuxi APP Neurological Biomarkers Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Neurological Biomarkers Market Competition by Market Players 4.1 Global Neurological Biomarkers Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Neurological Biomarkers Revenue Market Share by Market Players (2015-2020) 4.3 Global Neurological Biomarkers Average Price by Market Players (2015-2020) 5 Global Neurological Biomarkers Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Neurological Biomarkers Market Size (2015-2020) 5.1.2 Neurological Biomarkers Key Players in North America (2015-2020) 5.1.3 North America Neurological Biomarkers Market Size by Type (2015-2020) 5.1.4 North America Neurological Biomarkers Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Neurological Biomarkers Market Size (2015-2020) 5.2.2 Neurological Biomarkers Key Players in East Asia (2015-2020) 5.2.3 East Asia Neurological Biomarkers Market Size by Type (2015-2020) 5.2.4 East Asia Neurological Biomarkers Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Neurological Biomarkers Market Size (2015-2020) 5.3.2 Neurological Biomarkers Key Players in Europe (2015-2020) 5.3.3 Europe Neurological Biomarkers Market Size by Type (2015-2020) 5.3.4 Europe Neurological Biomarkers Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Neurological Biomarkers Market Size (2015-2020) 5.4.2 Neurological Biomarkers Key Players in South Asia (2015-2020) 5.4.3 South Asia Neurological Biomarkers Market Size by Type (2015-2020) 5.4.4 South Asia Neurological Biomarkers Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Neurological Biomarkers Market Size (2015-2020) 5.5.2 Neurological Biomarkers Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Neurological Biomarkers Market Size by Type (2015-2020) 5.5.4 Southeast Asia Neurological Biomarkers Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Neurological Biomarkers Market Size (2015-2020) 5.6.2 Neurological Biomarkers Key Players in Middle East (2015-2020) 5.6.3 Middle East Neurological Biomarkers Market Size by Type (2015-2020) 5.6.4 Middle East Neurological Biomarkers Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Neurological Biomarkers Market Size (2015-2020) 5.7.2 Neurological Biomarkers Key Players in Africa (2015-2020) 5.7.3 Africa Neurological Biomarkers Market Size by Type (2015-2020) 5.7.4 Africa Neurological Biomarkers Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Neurological Biomarkers Market Size (2015-2020) 5.8.2 Neurological Biomarkers Key Players in Oceania (2015-2020) 5.8.3 Oceania Neurological Biomarkers Market Size by Type (2015-2020) 5.8.4 Oceania Neurological Biomarkers Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Neurological Biomarkers Market Size (2015-2020) 5.9.2 Neurological Biomarkers Key Players in South America (2015-2020) 5.9.3 South America Neurological Biomarkers Market Size by Type (2015-2020) 5.9.4 South America Neurological Biomarkers Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Neurological Biomarkers Market Size (2015-2020) 5.10.2 Neurological Biomarkers Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Neurological Biomarkers Market Size by Type (2015-2020) 5.10.4 Rest of the World Neurological Biomarkers Market Size by Application (2015-2020) 6 Global Neurological Biomarkers Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Neurological Biomarkers Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Neurological Biomarkers Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Neurological Biomarkers Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Neurological Biomarkers Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Neurological Biomarkers Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Neurological Biomarkers Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Neurological Biomarkers Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Neurological Biomarkers Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Neurological Biomarkers Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Neurological Biomarkers Consumption by Countries 7 Global Neurological Biomarkers Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Neurological Biomarkers (2021-2026) 7.2 Global Forecasted Revenue of Neurological Biomarkers (2021-2026) 7.3 Global Forecasted Price of Neurological Biomarkers (2021-2026) 7.4 Global Forecasted Production of Neurological Biomarkers by Region (2021-2026) 7.4.1 North America Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.4.3 Europe Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.4.7 Africa Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.4.9 South America Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Neurological Biomarkers Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Neurological Biomarkers by Application (2021-2026) 8 Global Neurological Biomarkers Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Neurological Biomarkers by Country 8.2 East Asia Market Forecasted Consumption of Neurological Biomarkers by Country 8.3 Europe Market Forecasted Consumption of Neurological Biomarkers by Countriy 8.4 South Asia Forecasted Consumption of Neurological Biomarkers by Country 8.5 Southeast Asia Forecasted Consumption of Neurological Biomarkers by Country 8.6 Middle East Forecasted Consumption of Neurological Biomarkers by Country 8.7 Africa Forecasted Consumption of Neurological Biomarkers by Country 8.8 Oceania Forecasted Consumption of Neurological Biomarkers by Country 8.9 South America Forecasted Consumption of Neurological Biomarkers by Country 8.10 Rest of the world Forecasted Consumption of Neurological Biomarkers by Country 9 Global Neurological Biomarkers Sales by Type (2015-2026) 9.1 Global Neurological Biomarkers Historic Market Size by Type (2015-2020) 9.2 Global Neurological Biomarkers Forecasted Market Size by Type (2021-2026) 10 Global Neurological Biomarkers Consumption by Application (2015-2026) 10.1 Global Neurological Biomarkers Historic Market Size by Application (2015-2020) 10.2 Global Neurological Biomarkers Forecasted Market Size by Application (2021-2026) 11 Global Neurological Biomarkers Manufacturing Cost Analysis 11.1 Neurological Biomarkers Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Neurological Biomarkers 12 Global Neurological Biomarkers Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Neurological Biomarkers Distributors List 12.3 Neurological Biomarkers Customers 12.4 Neurological Biomarkers Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : Oct 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 160 |
Price : US$ 3,500 | Date : Oct 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 146 |
Price : US$ 3,500 | Date : Oct 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 148 |
Price : US$ 3,500 | Date : Oct 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 169 |
Price : US$ 3,500 | Date : Oct 2023 |
Category : Healthcare and Pharmaceuticals | Pages : 151 |
We will be happy to help you find what you need. Please call us or write to us: